MRI Patterns of the Hippocampus and Amygdala for Predicting Stages of Alzheimer's Progression: A Minimal Feature Machine Learning Framework
This work addresses the challenge of staging Alzheimer's disease for clinical applications, but it is incremental as it builds on existing methods with specific optimizations.
The study tackled the problem of accurately identifying stages of Alzheimer's progression, such as distinguishing late from early mild cognitive impairment, by proposing a minimal-feature machine learning framework using structural MRI data of the hippocampus and amygdala, achieving an accuracy of 88.46%.
Alzheimer's disease (AD) progresses through distinct stages, from early mild cognitive impairment (EMCI) to late mild cognitive impairment (LMCI) and eventually to AD. Accurate identification of these stages, especially distinguishing LMCI from EMCI, is crucial for developing pre-dementia treatments but remains challenging due to subtle and overlapping imaging features. This study proposes a minimal-feature machine learning framework that leverages structural MRI data, focusing on the hippocampus and amygdala as regions of interest. The framework addresses the curse of dimensionality through feature selection, utilizes region-specific voxel information, and implements innovative data organization to enhance classification performance by reducing noise. The methodology integrates dimensionality reduction techniques such as PCA and t-SNE with state-of-the-art classifiers, achieving the highest accuracy of 88.46%. This framework demonstrates the potential for efficient and accurate staging of AD progression while providing valuable insights for clinical applications.